Entering text into the input field will update the search result below

Neuralstem reports positive study results

Mar. 28, 2014 9:49 AM ETPalisade Bio, Inc. (PALI) StockBy: Douglas W. House, SA News Editor4 Comments
  • Shares of Neuralstem (CUR +9.6%) pop this morning in response to its report of positive results of NSI-566 in ischemic-stroke rats. Those receiving 10K - 20K cells/ul revealed statistically significant better results compared to those receiving 5K cells/ul.
  • NSI-566 is currently in a phase 2 trial for ALS.

Recommended For You

About PALI Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PALI--
Palisade Bio, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.